Manifestari cutanate in diabetul zaharat - PIM Copy
Manifestari cutanate in diabetul zaharat - PIM Copy
Manifestari cutanate in diabetul zaharat - PIM Copy
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Cupr<strong>in</strong>s<br />
1. CLASIFICAREA MANIFESTĂRILOR CUTANATE DIN<br />
DIABETUL ZAHARAT ..................................................................................................1<br />
1.1 CLASIFICAREA HUNLEY 57 – 1995 A MANIFESTĂRILOR CUTANATE DIN<br />
DIABETUL ZAHARAT .......................................................................................................1<br />
1.1 CLASIFICAREA PEREZ – KAHN 13 1994 A MANIFESTĂRILOR CUTANATE<br />
DIN DIABETUL ZAHARAT.................................................................................................2<br />
1.1 INCIDENŢA LEZIUNILOR CUTANATE LA PACIENŢII DIABETICI (STUDIUL<br />
YOSIPOVITCH 98 – 1997 ;2000)......................................................................................13<br />
2. NECROBIOSIS LIPOIDICA................................................................15<br />
2.1.ISTORIC...................................................................................................17<br />
2.2. PATOGENEZA .........................................................................................17<br />
2.2.1.Mecanismele patogenice propuse pentru necrobioza lipoidică (M.<br />
H. Lowitt, J. S. Dover 80<br />
-1991)................................................................................17<br />
2.2.2.Factorul genetic .............................................................................18<br />
2.2.3.Mecanism vascular.........................................................................18<br />
2.2.4.Disfuncţii nervoase sau ale glandelor sudoripare .........................21<br />
2.2.5.Anomalii de colagen.......................................................................22<br />
2.2.6.Lipidele...........................................................................................23<br />
2.2.7.Funcţia leucocitară anormală........................................................23<br />
2.2.8.Mecanismele imune........................................................................23<br />
2.3.EPIDEMIOLOGIE ......................................................................................25<br />
2.4.MANIFESTĂRI CLINICE............................................................................27<br />
2.5. VARIANTE CLINICE ................................................................................32<br />
2.6.HISTOPATOLOGIE....................................................................................34<br />
2.7.TRATAMENT ...........................................................................................38<br />
2.7.1.Tratament Medicamentos...............................................................39<br />
2.7.1.1.Corticosteroizii: ..................................................................................39<br />
2.7.1.2.Fibr<strong>in</strong>olitice.........................................................................................39<br />
2.7.1.3.Agenţi antiplachetari: Aspir<strong>in</strong>a/Dipiridamol.......................................40<br />
2.7.1.4.Ticlopid<strong>in</strong>a..........................................................................................41<br />
2.7.1.5.Ciclospor<strong>in</strong>a........................................................................................42<br />
2.7.1.6.Nicot<strong>in</strong>amida.......................................................................................42<br />
2.7.2.Tratament Chirurgical ...................................................................43